These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 11053251)
1. A gain of function p53 mutant promotes both genomic instability and cell survival in a novel p53-null mammary epithelial cell model. Murphy KL; Dennis AP; Rosen JM FASEB J; 2000 Nov; 14(14):2291-302. PubMed ID: 11053251 [TBL] [Abstract][Full Text] [Related]
2. Progesterone facilitates chromosome instability (aneuploidy) in p53 null normal mammary epithelial cells. Goepfert TM; McCarthy M; Kittrell FS; Stephens C; Ullrich RL; Brinkley BR; Medina D FASEB J; 2000 Nov; 14(14):2221-9. PubMed ID: 11053243 [TBL] [Abstract][Full Text] [Related]
3. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer. Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760 [TBL] [Abstract][Full Text] [Related]
4. Myc/p53 interactions in transgenic mouse mammary development, tumorigenesis and chromosomal instability. McCormack SJ; Weaver Z; Deming S; Natarajan G; Torri J; Johnson MD; Liyanage M; Ried T; Dickson RB Oncogene; 1998 May; 16(21):2755-66. PubMed ID: 9652742 [TBL] [Abstract][Full Text] [Related]
5. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors. Tzeng YJ; Zimmermann C; Guhl E; Berg B; Avantaggiati ML; Graessmann A Oncogene; 1998 Apr; 16(16):2103-14. PubMed ID: 9572491 [TBL] [Abstract][Full Text] [Related]
6. A transgenic mouse model for mammary carcinogenesis. Li B; Murphy KL; Laucirica R; Kittrell F; Medina D; Rosen JM Oncogene; 1998 Feb; 16(8):997-1007. PubMed ID: 9519874 [TBL] [Abstract][Full Text] [Related]
7. Arsenic promotes centrosome abnormalities and cell colony formation in p53 compromised human lung cells. Liao WT; Lin P; Cheng TS; Yu HS; Chang LW Toxicol Appl Pharmacol; 2007 Dec; 225(2):162-70. PubMed ID: 17945324 [TBL] [Abstract][Full Text] [Related]
8. Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells. Katayose D; Gudas J; Nguyen H; Srivastava S; Cowan KH; Seth P Clin Cancer Res; 1995 Aug; 1(8):889-97. PubMed ID: 9816059 [TBL] [Abstract][Full Text] [Related]
9. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997 [TBL] [Abstract][Full Text] [Related]
10. Loss of Brca2 and p53 synergistically promotes genomic instability and deregulation of T-cell apoptosis. Cheung AM; Hande MP; Jalali F; Tsao MS; Skinnider B; Hirao A; McPherson JP; Karaskova J; Suzuki A; Wakeham A; You-Ten A; Elia A; Squire J; Bristow R; Hakem R; Mak TW Cancer Res; 2002 Nov; 62(21):6194-204. PubMed ID: 12414647 [TBL] [Abstract][Full Text] [Related]
11. Genomic instability and apoptosis are frequent in p53 deficient young mice. Fukasawa K; Wiener F; Vande Woude GF; Mai S Oncogene; 1997 Sep; 15(11):1295-302. PubMed ID: 9315097 [TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 E6 inactivation of p53 in normal human mammary epithelial cells promotes tamoxifen-mediated apoptosis. Seewaldt VL; Mrózek K; Dietze EC; Parker M; Caldwell LE Cancer Res; 2001 Jan; 61(2):616-24. PubMed ID: 11212259 [TBL] [Abstract][Full Text] [Related]
13. Preferential overexpression of a 172Arg-->Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development. Li B; Greenberg N; Stephens LC; Meyn R; Medina D; Rosen JM Cell Growth Differ; 1994 Jul; 5(7):711-21. PubMed ID: 7947386 [TBL] [Abstract][Full Text] [Related]
14. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Xu X; Wagner KU; Larson D; Weaver Z; Li C; Ried T; Hennighausen L; Wynshaw-Boris A; Deng CX Nat Genet; 1999 May; 22(1):37-43. PubMed ID: 10319859 [TBL] [Abstract][Full Text] [Related]
16. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis. Hollmann CA; Kittrell FS; Medina D; Butel JS Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642 [TBL] [Abstract][Full Text] [Related]
17. Genomic convergence and suppression of centrosome hyperamplification in primary p53-/- cells in prolonged culture. Chiba S; Okuda M; Mussman JG; Fukasawa K Exp Cell Res; 2000 Aug; 258(2):310-21. PubMed ID: 10896782 [TBL] [Abstract][Full Text] [Related]
18. Abrogation of wild-type p53-mediated transactivation is insufficient for mutant p53-induced immortalization of normal human mammary epithelial cells. Cao Y; Gao Q; Wazer DE; Band V Cancer Res; 1997 Dec; 57(24):5584-9. PubMed ID: 9407971 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function. Bracey TS; Williams AC; Paraskeva C Clin Cancer Res; 1997 Aug; 3(8):1371-81. PubMed ID: 9815821 [TBL] [Abstract][Full Text] [Related]
20. Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer. Milliken EL; Lozada KL; Johnson E; Landis MD; Seachrist DD; Whitten I; Sutton AL; Abdul-Karim FW; Keri RA Oncogene; 2008 Mar; 27(12):1759-66. PubMed ID: 17891171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]